IMCC vs. MTEX, UPXI, PAVS, HAPP, BON, AKAN, SMFL, SNDL, TLRY, and CRON
Should you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Mannatech (MTEX), Upexi (UPXI), Paranovus Entertainment Technology (PAVS), Happiness Development Group (HAPP), Bon Natural Life (BON), Akanda (AKAN), Smart for Life (SMFL), SNDL (SNDL), Tilray (TLRY), and Cronos Group (CRON). These companies are all part of the "medicinals & botanicals" industry.
Mannatech (NASDAQ:MTEX) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings.
Mannatech has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500.
Mannatech has a net margin of -1.31% compared to Mannatech's net margin of -28.03%. IM Cannabis' return on equity of -15.37% beat Mannatech's return on equity.
13.0% of Mannatech shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 41.5% of Mannatech shares are held by insiders. Comparatively, 5.9% of IM Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Mannatech has higher revenue and earnings than IM Cannabis. Mannatech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.
In the previous week, IM Cannabis had 2 more articles in the media than Mannatech. MarketBeat recorded 4 mentions for IM Cannabis and 2 mentions for Mannatech. IM Cannabis' average media sentiment score of 0.94 beat Mannatech's score of 0.30 indicating that Mannatech is being referred to more favorably in the media.
Mannatech received 278 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 74.93% of users gave Mannatech an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote.
Summary
Mannatech beats IM Cannabis on 11 of the 15 factors compared between the two stocks.
Get IM Cannabis News Delivered to You Automatically
Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IMCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IM Cannabis Competitors List
Related Companies and Tools
